Understand the source comparison
Direct Answer: SubQ vs IM for SS-LUP-332
The default assumption. That intramuscular injection always delivers superior peptide absorption. Doesn't hold for compounds in the 2,000–5,000 Da molecular weight range like SS-LUP-332. Subcutaneous administration leverages slower lymphatic uptake and adipose
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The default assumption. That intramuscular injection always delivers superior peptide absorption. Doesn't hold for compounds in the 2,000–5,000 Da molecular weight range like SS-LUP-332. Subcutaneous administration leverages slower lymphatic uptake and adipose tissue buffering, which prevents the rapid plasma concentration spike-and-crash pattern seen with IM routes. This isn't about convenience. It's about matching absorption kinetics to the biological pathway you're investigating. This article covers the pharmacokinetic differences between SubQ and IM administration for SS-LUP-332, tissue-level inflammatory response data, and how injection site selection impacts reproducibility across multi-day protocols.